Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
- GLP-1 Medications Could Treat Addiction
- Every Samsung Music lifestyle speaker is cheaper in the US right now
- Measles spread in Wisconsin; almost everyone made ill is unvaccinated, health officials say
- Pediatrician offers tips to prevent childhood obesity: Woman’s Doctor
- Column: Joel Samberg’s wish list for the gym
- Kentucky shines with ‘Food Is Medicine’ movement and prescriptive food pantries
- New ‘Immunize Minnesota’ coalition hopes to break down public health silos around vaccines
- COVID in Kids: Symptoms, Treatment & When to See a Doctor
Browsing: Samsung
Samsung’s Music Frame and Music Studio speakers are discounted in the US for a limited time. You can save up to $100 on the Music Frame (2024), $50 on the Music Studio 5, and $80 on the Music Studio 7
AI is being widely used to analyze biosignals measured by wearable devices such as smartwatches. By identifying meaningful patterns in health data — including sleep, heart rate, and physical activity — AI is helping users better understand and manage their health
|| New lifestyle convenience services introduced on Samsung C&T’s home platform Homnic. Photo courtesy of Samsung C&T
Samsung Malaysia Recognised for Leadership in Smart Technology and Digital Lifestyle Solutions at The BrandLaureate Lifestyle BestBrands Awards 2026 – Samsung Newsroom Malaysia
This is a paid press release. Contact the press release distributor directly with any inquiries.
Deeper insights, more accurate tracking and lasting comfort help users turn daily data into actionable guidance
Today, health information is often fragmented across multiple devices, apps, and services, making it difficult for people to build a complete understanding of their overall wellness. While access to health data has never been greater, many users still struggle to interpret what their data means and understand how they can make meaningful changes in their…
Samsung Biologics has offered to buy PolyPeptide for CHF 1.46 billion ($1.8 billion), marking a move into peptide manufacturing
Samsung Biologics (207940.KS) has made the largest investment in the history of Korean pharmaceutical and biotech mergers and acquisitions (M&A) to enter the peptide contract development and manufacturing organization (CDMO) business, aiming to secure a competitive edge in the global obesity treatment market, which is expected to grow to 200 trillion won over the next…
Samsung Biologics is acquiring PolyPeptide, a global peptide contract development and manufacturing organization (CDMO), for about 2.7 trillion won ($1.8 billion) — the largest acquisition in the local pharmaceutical and biotech industry

